Probiotics for Preventing Late-Onset Sepsis in Preterm Neonates: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials
- PMID: 26937897
- PMCID: PMC4778994
- DOI: 10.1097/MD.0000000000002581
Probiotics for Preventing Late-Onset Sepsis in Preterm Neonates: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials
Abstract
The effect of probiotics on late-onset sepsis (LOS) in preterm neonates remains controversial. The authors systematically reviewed the literature to investigate whether enteral probiotic supplementation reduced the risk of LOS in preterm neonates in neonatal intensive care units.PubMed, Embase, and Cochrane Central Register of Controlled Trials were systematically searched for randomized controlled trials (RCTs) regarding the effect of probiotics in preterm neonates. The primary outcome was culture-proven bacterial and/or fungal sepsis. The Mantel-Haenszel method with random-effects model was used to calculate pooled relative risks (RRs) and 95% confidence intervals (CIs).Twenty-seven trials were included in our review, and 25 trials involving 6104 preterm neonates were statistically analyzed. Pooled analysis indicated that enteral probiotic supplementation significantly reduced the risk of any sepsis (25 RCTs; RR 0.83, 95% CI 0.73-0.94; I = 26%), bacterial sepsis (11 RCTs; RR 0.82, 95% CI 0.71-0.95; I = 0%), and fungal sepsis (6 RCTs; RR 0.57, 95% CI 0.41-0.78; I = 0%). This beneficial effect remains in very low birth weight infants (<1500 g) (19 RCTs; RR 0.86, 95% CI 0.75-0.97; I = 18%), but not in extremely low birth weight infants (<1000 g) (3 RCTs; RR 0.73, 95% CI 0.45-1.19; I = 53%). All the included trials reported no systemic infection caused by the supplemental probiotic organisms.Current evidence indicates that probiotic supplementation is safe, and effective in reducing the risk of LOS in preterm neonates in neonatal intensive care units. Further studies are needed to address the optimal probiotic organism, dosing, timing, and duration. High-quality and adequately powered RCTs regarding the efficacy and safety of the use of probiotics in extremely low birth weight infants are still warranted.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD007137. doi: 10.1002/14651858.CD007137.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Mar 31;3:CD007137. doi: 10.1002/14651858.CD007137.pub6. PMID: 28658720 Free PMC article. Updated.
-
Probiotics Prevent Candida Colonization and Invasive Fungal Sepsis in Preterm Neonates: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Pediatr Neonatol. 2017 Apr;58(2):103-110. doi: 10.1016/j.pedneo.2016.06.001. Epub 2016 Sep 14. Pediatr Neonatol. 2017. PMID: 27793494
-
Probiotics for prevention of necrotizing enterocolitis in preterm infants.Cochrane Database Syst Rev. 2008 Jan 23;(1):CD005496. doi: 10.1002/14651858.CD005496.pub2. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2011 Mar 16;(3):CD005496. doi: 10.1002/14651858.CD005496.pub3. PMID: 18254081 Updated.
-
Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.Cochrane Database Syst Rev. 2023 Jul 26;7(7):CD005496. doi: 10.1002/14651858.CD005496.pub6. Cochrane Database Syst Rev. 2023. PMID: 37493095 Free PMC article.
-
Prophylactic lactoferrin for preventing late-onset sepsis and necrotizing enterocolitis in preterm infants: A PRISMA-compliant systematic review and meta-analysis.Medicine (Baltimore). 2018 Aug;97(35):e11976. doi: 10.1097/MD.0000000000011976. Medicine (Baltimore). 2018. PMID: 30170397 Free PMC article.
Cited by
-
NutriBrain: protocol for a randomised, double-blind, controlled trial to evaluate the effects of a nutritional product on brain integrity in preterm infants.BMC Pediatr. 2021 Mar 17;21(1):132. doi: 10.1186/s12887-021-02570-x. BMC Pediatr. 2021. PMID: 33731062 Free PMC article.
-
Transmission of Group B Streptococcus in late-onset neonatal disease: a narrative review of current evidence.Ther Adv Infect Dis. 2022 Dec 21;9:20499361221142732. doi: 10.1177/20499361221142732. eCollection 2022 Jan-Dec. Ther Adv Infect Dis. 2022. PMID: 36569815 Free PMC article. Review.
-
[Expert consensus on enteral nutrition management of preterm infants (2024)].Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jun 15;26(6):541-552. doi: 10.7499/j.issn.1008-8830.2402039. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 38926369 Free PMC article. Chinese.
-
Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients.Nat Med. 2019 Nov;25(11):1728-1732. doi: 10.1038/s41591-019-0626-9. Epub 2019 Nov 7. Nat Med. 2019. PMID: 31700189 Free PMC article.
-
Lactiplantibacillus plantarum-Nomad and Ideal Probiotic.Front Microbiol. 2021 Oct 6;12:712236. doi: 10.3389/fmicb.2021.712236. eCollection 2021. Front Microbiol. 2021. PMID: 34690957 Free PMC article. Review.
References
-
- Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110:285–291. - PubMed
-
- Payne NR, Carpenter JH, Badger GJ, et al. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 2004; 114:348–355. - PubMed
-
- Manzoni P, Rizzollo S, Decembrino L, et al. Recent advances in prevention of sepsis in the premature neonates in NICU. Early Hum Dev 2011; 87:S31–S33. - PubMed
-
- Magne F, Suau A, Pochart P, et al. Fecal microbial community in preterm infants. J Pediatr Gastroenterol Nutr 2005; 41:386–392. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical